Latest Lead News

Objective Corporation reports robust FY2025 results with strong recurring revenue growth and deepening AI integration, setting ambitious targets for FY2026.

Resource Minerals International Ltd has acquired a 50% interest in a Saudi Arabian joint venture, gaining access to the highly prospective Shaib Marqan gold and base metals exploration licence. This move positions RMI to leverage Saudi Arabia’s expanding mining sector under Vision 2030 reforms.

WIN Metals has secured $2.35 million through a heavily oversubscribed placement to accelerate drilling at its high-grade Radio Gold Mine and advance resource evaluation at Butchers Creek.

Godolphin Resources has revealed promising high-grade copper and gold assay results from its Summers West and Little Bell prospects, highlighting significant expansion potential beyond the current Lewis Ponds resource boundary.

Prominence Energy Limited has secured a pivotal natural hydrogen exploration license in South Australia, marking a major step forward for its Gawler Hydrogen Project and positioning it among the state’s leading clean energy explorers.

Cannindah Resources Limited has voluntarily suspended its shares from trading as it prepares to announce a significant capital raising. The suspension is set to last until the announcement or the resumption of trading on August 22.

Peet Limited delivered a robust FY25 performance with a 60% jump in net operating profit and a strong sales pipeline, while initiating a strategic review to capitalize on favorable market conditions.

MA Financial Group reported a robust 30% revenue increase for the first half of 2025, yet statutory net profit fell sharply by 44%, highlighting a complex financial landscape as the firm prepares to acquire IP Generation.

Sonic Healthcare Limited has announced an ordinary dividend of AUD 0.63 per share for the first half of 2025, with a 35% franking component and payment scheduled for mid-September.

Qube Holdings delivered a robust FY25 performance with underlying revenue up 27.3% and a 7.1% dividend increase, despite a significant impairment of its MITCo investment. The company’s diversified logistics and grain trading operations powered growth amid industrial and weather challenges.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

Infinity Mining’s re-assay of historic stream sediment samples at its Tanjil Bren Project reveals elevated gold and pathfinder elements, highlighting promising intrusion-related gold system signatures.